Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Morten Lock Hansen

Showing results (121-130 of 131) with videos related to

Pageof 14
Sort By:
Annals of Internal Medicine|November 18, 2014
Relation of nonsteroidal anti-inflammatory drugs to serious bleeding and thromboembolism risk in patients with atrial fibrillation receiving antithrombotic therapy: a nationwide cohort studyMorten Lamberts, Gregory Y H Lip, Morten Lock Hansen, et al.
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|December 18, 2023
Two decades of SVT ablation in Denmark: a trend towards higher age, more comorbidity, and less prior use of antiarrhythmic and rate-limiting pharmacotherapy-a nationwide registry-based Danish studyCharlotte Middelfart, Jacob Tønnesen, Christopher R Zörner, et al.
Heart (British Cardiac Society)|February 8, 2025
Prognostic implications of iron deficiency in patients with atrial fibrillation, with and without chronic heart failureAbdullahi Ahmed Mohamed, Daniel Mølager Christensen, Milan Mohammad, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|November 20, 2019
Risk of gastrointestinal bleeding associated with oral anticoagulation and non-steroidal anti-inflammatory drugs in patients with atrial fibrillation: a nationwide studyAnne-Marie Schjerning Olsen, Patricia McGettigan, Thomas Alexander Gerds, et al.
Thrombosis Research|January 23, 2021
Effect of government interventions to contain the COVID-19 pandemic on incidence of pulmonary embolism - A Danish nationwide register-based cohort studyCaroline Sindet-Pedersen, Jonas Bjerring Olesen, Paul Blanche, et al.
European Heart Journal|February 8, 2020
Gastrointestinal bleeding and the risk of colorectal cancer in anticoagulated patients with atrial fibrillationPeter Vibe Rasmussen, Frederik Dalgaard, Gunnar Hilmar Gislason, et al.
Heart Rhythm|August 15, 2024
Prognostic importance of ischemic heart disease for patients with atrial fibrillation undergoing catheter ablationCaroline Espersen, Daniel Modin, Niklas Dyrby Johansen, et al.
Cardiovascular Diabetology|August 2, 2025
Erythrocytosis incidence and thromboembolic risk in heart failure with reduced ejection fraction treated with SGLT2 inhibitors: a nationwide register-based cohort studyAbdullahi Ahmed Mohamed, Camilla Fuchs Andersen, Daniel Mølager Christensen, et al.
The American Journal of Cardiology|August 21, 2023
Association Between Pulmonary Vascular Volume and Cardiac Structure and Function in Patients With Atrial FibrillationAnne Bjerg Nielsen, Kristoffer Grundtvig Skaarup, Kasper Djernæs, et al.
Heart Rhythm|May 31, 2025
Inflammation and risk of cardiovascular outcomes in patients with atrial fibrillation and flutter: A nationwide registry studyAdam Femerling Langhoff, Daniel Modin, Maria Dons, et al.
Pageof 14

Showing results (121-130 of 131) with videos related to

Sort By:
Pageof 14
Annals of Internal Medicine|November 18, 2014
Relation of nonsteroidal anti-inflammatory drugs to serious bleeding and thromboembolism risk in patients with atrial fibrillation receiving antithrombotic therapy: a nationwide cohort studyMorten Lamberts, Gregory Y H Lip, Morten Lock Hansen, et al.
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|December 18, 2023
Two decades of SVT ablation in Denmark: a trend towards higher age, more comorbidity, and less prior use of antiarrhythmic and rate-limiting pharmacotherapy-a nationwide registry-based Danish studyCharlotte Middelfart, Jacob Tønnesen, Christopher R Zörner, et al.
Heart (British Cardiac Society)|February 8, 2025
Prognostic implications of iron deficiency in patients with atrial fibrillation, with and without chronic heart failureAbdullahi Ahmed Mohamed, Daniel Mølager Christensen, Milan Mohammad, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|November 20, 2019
Risk of gastrointestinal bleeding associated with oral anticoagulation and non-steroidal anti-inflammatory drugs in patients with atrial fibrillation: a nationwide studyAnne-Marie Schjerning Olsen, Patricia McGettigan, Thomas Alexander Gerds, et al.
Thrombosis Research|January 23, 2021
Effect of government interventions to contain the COVID-19 pandemic on incidence of pulmonary embolism - A Danish nationwide register-based cohort studyCaroline Sindet-Pedersen, Jonas Bjerring Olesen, Paul Blanche, et al.
European Heart Journal|February 8, 2020
Gastrointestinal bleeding and the risk of colorectal cancer in anticoagulated patients with atrial fibrillationPeter Vibe Rasmussen, Frederik Dalgaard, Gunnar Hilmar Gislason, et al.
Heart Rhythm|August 15, 2024
Prognostic importance of ischemic heart disease for patients with atrial fibrillation undergoing catheter ablationCaroline Espersen, Daniel Modin, Niklas Dyrby Johansen, et al.
Cardiovascular Diabetology|August 2, 2025
Erythrocytosis incidence and thromboembolic risk in heart failure with reduced ejection fraction treated with SGLT2 inhibitors: a nationwide register-based cohort studyAbdullahi Ahmed Mohamed, Camilla Fuchs Andersen, Daniel Mølager Christensen, et al.
The American Journal of Cardiology|August 21, 2023
Association Between Pulmonary Vascular Volume and Cardiac Structure and Function in Patients With Atrial FibrillationAnne Bjerg Nielsen, Kristoffer Grundtvig Skaarup, Kasper Djernæs, et al.
Heart Rhythm|May 31, 2025
Inflammation and risk of cardiovascular outcomes in patients with atrial fibrillation and flutter: A nationwide registry studyAdam Femerling Langhoff, Daniel Modin, Maria Dons, et al.
Pageof 14